A Review of Economic Models Submitted to NICE's Technology Appraisal Programme, for Treatments of T1DM & T2DM. [PDF]
Front Pharmacol, 2022 Background: In the UK, 4.7 million people are currently living with diabetes. This is projected to increase to 5 million by 2025. The direct and indirect costs of T1DM and T2DM are rising, and direct costs already account for approximately 10% of the ...
Daly MJ +3 more
europepmc +3 more sources
Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process. [PDF]
Pharmacoecon Open, 2017 Kaltenthaler E +8 more
europepmc +1 more source
Urban evolution of insecticide resistance and susceptibility patterns of Anopheles coluzzii in Southeastern Nigeria: implications for malaria vector control. [PDF]
Malar JEzeike AK +9 more
europepmc +1 more source
Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study [PDF]
, 2021 INTRODUCTION: For people with type 2 diabetes mellitus (T2DM) who require an antidiabetic drug as an add-on to metformin, there is controversy about whether newer drug classes such as dipeptidyl peptidase-4 inhibitors (DPP4i) or sodium-glucose co ...
Adler, AI +12 more
core +4 more sources
Prescribing in type 2 diabetes patients with and without cardiovascular disease history: A descriptive analysis in the UK CPRD [PDF]
, 2021 PURPOSE: Some classes of glucose-lowering medications, including sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide 1-receptor agonists (GLP1-RAs) have cardio-protective benefit, but it is unclear whether this influences ...
Beard, Ivan +8 more
core +1 more source
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment in people with type 2 diabetes in England: a cross-sectional study. [PDF]
, 2022 AIMS: To assess any disparities in the initiation of second-line antidiabetic treatments prescribed among people with type 2 diabetes mellitus (T2DM) in England according to ethnicity and social deprivation.
Adler, Amanda I +12 more
core +1 more source
SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus : a systematic review and network meta-analysis [PDF]
, 2016 Objective Because of the lack of head-to-head trials, the aim was to indirectly compare sodium glucose transporter-2 (SGLT-2) inhibitors in the treatment of type 2 diabetes. Design Systematic review and network meta-analysis.
Shyangdan, Deepson S. +2 more
core +1 more source
Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK [PDF]
, 2019 In people with Type 2 diabetes, cardiovascular disease is a leading cause of morbidity and mortality. Thus, as well as controlling glucose, reducing the risk of cardiovascular events is a key goal. The results of cardiovascular outcome trials have led to
Strain, W David
core +6 more sources
Approbation of Results Obtained During Interview: Research of Possibilities for Exercising the Rights of Political Oppositions in Lithuanian Self-Government [PDF]
, 2021 Analysing the problematic aspects of the legal regulation of local self-government of the Republic of Lithuania related to the realisation of the rights provided for the minority (opposition) of the municipal council in the Law on Local Self-Government ...
Kaklys, Karolis
core +1 more source
Cave shrimps Troglocaris s. str. (Dormitzer, 1853), taxonomic revision and description of new taxa after phylogenetic and morphometric studies [PDF]
, 2012 FIGURE 1. Distribution map of eight taxa of the subgenus Troglocaris s. str., with phylogroup/subgroup designation (in brackets, as in Zakšek et al. 2009).
Jalžić, Branko +3 more
core +2 more sources